Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Biocon’s Insulin Glargine receives regulatory approval in Japan
The product is ready to be launched in Q1 FY17
DRL in agreement with XenoPort
DRL will be granted exclusive US rights for the development and commercialisation of XenoPort’s clinical-stage oral new chemical…
Glenmark receives US FDA approval for bendamustine hydrochloride injection
It is Glenmark’s first injectable approval in the US
Cadila Pharma initiates awareness campaigns to observe ‘World TB Day’
Multi-city patient awareness programmes, free diagnosis, rallies, radio, street play and film activity has been planned to raise…
MSF welcomes Ministry of Commerce clarification on Compulsory Licensing
Warns US pressure on India will continue
The Ministry of Commerce recently clarified that media reports claiming that the…
Torrent Pharma seeks shareholder approval for equity raise and borrowing plans
The move will help the company to take quick and effective actions to capitalise on opportunities
Sun Pharma partners with AstraZeneca India over Type II diabetes medicine
Under the agreement, Sun Pharma will promote and distribute dapagliflozin under the brand name 'Oxra'
Bioproduction 2016
Bioproduction 2016 will provide a platform for the key biologic manufacturers from across Asia Pacific and rest of the world to…
SDI, FICCI & Express Pharma discuss ‘Innovation & International Competitiveness’
The roundtable explored opportunities in life sciences that India and Scotland can leverage to complement each other
JP Nadda launches new anti-TB drug
Bedaquiline is being introduced at six identified tertiary care centres across India